Metlife Stock Performance
| MET Stock | USD 69.95 1.03 1.49% |
MetLife has a performance score of 2 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.64, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MetLife's returns are expected to increase less than the market. However, during the bear market, the loss of holding MetLife is expected to be smaller as well. MetLife right now secures a risk of 1.14%. Please verify MetLife potential upside, as well as the relationship between the kurtosis and day typical price , to decide if MetLife will be following its current price movements.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in MetLife are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, MetLife is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
One Day Return (0.01) | Five Day Return (2.34) | Year To Date Return 2.33 | Ten Year Return 51.17 | All Time Return 399.06 |
Forward Dividend Yield 0.0302 | Payout Ratio 0.2834 | Last Split Factor 1122:1000 | Forward Dividend Rate 2.08 | Dividend Date 2024-03-14 |
1 | MetLife, Inc. Shares Sold by Itau Unibanco Holding S.A. | 02/28/2024 |
2 | Wellington Management Group LLP Has 1.62 Billion Position in MetLife, Inc. | 03/12/2024 |
3 | Disposition of 4026 shares by Ramy Tadros of MetLife at 71.9025 subject to Rule 16b-3 | 03/13/2024 |
| MetLife dividend paid on 14th of March 2024 | 03/14/2024 |
4 | Segway-Ninebot APACMET Distribtrler Konferans 2024 novasyon ve Mkemmeliyetin Birleimi | 03/22/2024 |
5 | MetLife Recognized As 2024 Energy Star Partner of the Year for Sixth Consecutive Year | 03/26/2024 |
6 | HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Nave or Previously Treated Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC | 03/28/2024 |
7 | State of Alaska Department of Revenue Has 5.31 Million Position in MetLife, Inc. - MarketBeat | 04/02/2024 |
8 | MetLife Named to Fortune Magazines 2024 List of the 100 Best Companies to Work For | 04/04/2024 |
9 | MetLife Pet Insurance Announces Collaboration with The Association of Animal Welfare Advancement | 04/09/2024 |
10 | MetLifes Connected Benefits to Enhance Employer Offerings | 04/12/2024 |
11 | MetLife Launches Savings Calculator to Educate Pet Parents | 04/17/2024 |
| Begin Period Cash Flow | 20.2 B |
MetLife |
MetLife Relative Risk vs. Return Landscape
If you would invest 6,835 in MetLife on January 19, 2024 and sell it today you would earn a total of 160.00 from holding MetLife or generate 2.34% return on investment over 90 days. MetLife is generating 0.0432% of daily returns assuming volatility of 1.1361% on return distribution over 90 days investment horizon. In other words, 10% of stocks are less volatile than MetLife, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
MetLife Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MetLife's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MetLife, and traders can use it to determine the average amount a MetLife's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.038
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MET |
Estimated Market Risk
| 1.14 actual daily | 10 90% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average MetLife is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MetLife by adding it to a well-diversified portfolio.
MetLife Fundamentals Growth
MetLife Stock prices reflect investors' perceptions of the future prospects and financial health of MetLife, and MetLife fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MetLife Stock performance.
| Return On Equity | 0.0531 | |||
| Return On Asset | 0.003 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 69.42 B | |||
| Shares Outstanding | 723.02 M | |||
| Price To Earning | 28.61 X | |||
| Price To Book | 1.69 X | |||
| Price To Sales | 0.76 X | |||
| Revenue | 66.41 B | |||
| Gross Profit | 14.89 B | |||
| EBITDA | 2.36 B | |||
| Net Income | 1.6 B | |||
| Cash And Equivalents | 20.2 B | |||
| Cash Per Share | 41.28 X | |||
| Total Debt | 18.83 B | |||
| Debt To Equity | 4.11 % | |||
| Current Ratio | 1.11 X | |||
| Book Value Per Share | 41.07 X | |||
| Cash Flow From Operations | 13.72 B | |||
| Earnings Per Share | 1.81 X | |||
| Market Capitalization | 49.84 B | |||
| Total Asset | 687.58 B | |||
| Retained Earnings | 40.15 B | |||
About MetLife Performance
To evaluate MetLife Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when MetLife generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare MetLife Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand MetLife market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents MetLife's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.00 | 0.00 | |
| Return On Tangible Assets | 0 | 0 | |
| Return On Capital Employed | 0 | 0 | |
| Return On Assets | 0 | 0 | |
| Return On Equity | 0.05 | 0.09 |
Things to note about MetLife performance evaluation
Checking the ongoing alerts about MetLife for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MetLife help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 76.0% of the company shares are owned by institutional investors | |
| On 14th of March 2024 MetLife paid $ 0.52 per share dividend to its current shareholders | |
| Latest headline from zacks.com: MetLife Launches Savings Calculator to Educate Pet Parents |
- Analyzing MetLife's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MetLife's stock is overvalued or undervalued compared to its peers.
- Examining MetLife's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MetLife's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MetLife's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MetLife's stock. These opinions can provide insight into MetLife's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.Note that the MetLife information on this page should be used as a complementary analysis to other MetLife's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for MetLife Stock analysis
When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stocks Directory Find actively traded stocks across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is MetLife's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetLife. If investors know MetLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MetLife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Dividend Share 2.06 | Earnings Share 1.81 | Revenue Per Share 88.295 | Quarterly Revenue Growth 0.219 |
The market value of MetLife is measured differently than its book value, which is the value of MetLife that is recorded on the company's balance sheet. Investors also form their own opinion of MetLife's value that differs from its market value or its book value, called intrinsic value, which is MetLife's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MetLife's market value can be influenced by many factors that don't directly affect MetLife's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MetLife's value and its price as these two are different measures arrived at by different means. Investors typically determine if MetLife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MetLife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.